| 2000 | | A novel germ line juxtamembrane Met mutation in human gastric cancer. | 이재호, 조혜성, 한상욱 |
| 2015 | | A novel isoform of met receptor tyrosine kinase blocks hepatocyte growth factor/Met signaling and stimulates skeletal muscle cell differentiation. | 김철호, 이광, 이복순, 이재호, 조혜성 |
| 2014 | | A putative pH-dependent nuclear localization signal in the juxtamembrane region of c-Met. | 권명희, 이재호 |
| 1999 | | A src-related kinase in the brush border membranes of gastrointestinal cells is regulated by c-met. | 이재호 |
| 2015 | | Adenovirus expressing dual c-Met-specific shRNA exhibits potent antitumor effect through autophagic cell death accompanied by senescence-like phenotypes in glioblastoma cells. | 최경숙 |
| 2006 | | An alternatively spliced form of Met receptor is tumorigenic. | 이재호 |
| 2010 | | c-Met expression as an indicator of survival outcome in patients with oral tongue carcinoma. | 김철호, 이진석, 한재호 |
| 2007 | | Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma. | 김장희, 김철호 |
| 2011 | | Epigallocatechin-3-gallate inhibits paracrine and autocrine hepatocyte growth factor/scatter factor-induced tumor cell migration and invasion. | 김명덕, 배기수, 이재호 |
| 2011 | | Green tea (-)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met. | 김철호, 이영돈 |
| 2005 | | Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. | 김욱환 |
| 2016 | | Increased MACC1 expression indicates a poor prognosis independent of MET expression in gastric adenocarcinoma | 고영화, 이다근, 허훈 |
| 2015 | | Insulin-like growth factor-1 receptor is associated with better prognosis in classical Hodgkin's lymphoma: Correlation with MET expression. | 고영화 |
| 2018 | | Keratin 19 Expression in Hepatocellular Carcinoma Is Regulated by Fibroblast-Derived HGF via a MET-ERK1/2-AP1 and SP1 Axis | 우현구, 최지혜 |
| 2014 | | Met degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression. | 강성운, 김철호, 이복순 |
| 2014 | | MET expression is associated with disease-specific survival in breast cancer patients in the neoadjuvant setting. | 고영화 |
| 2015 | | MET is a predictive factor for late recurrence but not for overall survival of early stage hepatocellular carcinoma. | 고영화 |
| 2024 | | MET overexpression in ovarian cancer via CD24-induced downregulation of miR-181a: A signalling for cellular quiescence-like state and chemoresistance in ovarian CSCs | 권지은 |
| 2005 | | Presence of autocrine hepatocyte growth factor-Met signaling and its role in proliferation and migration of SNU-484 gastric cancer cell line. | 김욱환, 박민선, 이재호, 조혜성 |
| 2021 | | Quantitation of ligand is critical for ligand-dependent MET signalling activation and determines MET-targeted therapeutic response in gastric cancer | 김석휘, 이다근, 한재호 |
| 2016 | | The Dual Inhibition of Met and EGFR by ME22S, a Novel Met/EGFR Bispecific Monoclonal Antibody, Suppresses the Proliferation and Invasion of Laryngeal Cancer | 김철호, 이복순 |
| 2004 | | Transforming variant of Met receptor confers serum independence and anti-apoptotic property and could be involved in the mouse thymic lymphomagenesis. | 이재호 |
